Form 4: Biote Corp. CEO Bret Christensen Reports Stock Purchase
SEC Form 4 Filing
Biote Corp. CEO Bret Christensen reports purchasing 37,595 shares of Class A Common Stock at an average price of $3.87 on March 17, 2025.
Summary
- Bret Christensen, the CEO of Biote Corp., reported a transaction involving the company's Class A Common Stock on March 17, 2025.
- He purchased 37,595 shares at a weighted average price of $3.87.
- The shares were bought in multiple transactions with prices ranging from $3.55 to $4.00.
- Following the reported transaction, Mr. Christensen disposed of 37,595 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock transactions by an insider. The purchase could be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may view the CEO's stock purchase as a positive sign of confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of stock purchase transaction |
| 03/18/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.